stockrowICON PLC
ICLR Healthcare Diagnostics & Research
ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024.
- Revenue
- −2.86%
- EPS
- +143.2%
- Free cash flow
- −8.01%
- Total debt
- −0.86%
Quarter to September 2026, against a year earlier
Follow ICLR
Alert me
ICON PLC (ICLR) Current ratio
ICON PLC's current ratio at the end of the quarter to 30 September 2026 was 1.3×, up 0.2× from fiscal 2025 (1.1×). Over the past ten years it has ranged from 1.1× (fiscal 2025) to 2.2× (fiscal 2018) — the current reading is the lowest in ten years. That is below the Diagnostics & Research industry median of 2.3× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.1× | (11.84%) |
| FY2024 | 1.2× | 2.93% |
| FY2023 | 1.2× | 0.60% |
| FY2022 | 1.2× | 1.15% |
| FY2021 | 1.2× | (36.59%) |
| FY2020 | 1.9× | 30.26% |
| FY2019 | 1.4× | (34.06%) |
| FY2018 | 2.2× | 11.99% |
| FY2017 | 1.9× | 0.39% |
| FY2016 | 1.9× | 28.42% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 1.3× | 38.05% |
| Jun 2026 | 1.0× | (16.29%) |
| Mar 2026 | 1.1× | 3.88% |
| Dec 2025 | 1.1× | 3.48% |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| GH Guardant Health, Inc. compare | 3.6× |
| QGEN QIAGEN N.V. compare | 2.8× |
| RVTY Revvity Inc. compare | 2.7× |
| ILMN Illumina, Inc. compare | 2.6× |
| DGX Quest Diagnostics Incorporated compare | 1.7× |
| CRL Charles River Laboratories International, Inc. compare | 1.4× |
| LH Labcorp Holdings Inc. compare | 1.4× |
| ICLR ICON PLC | 1.3× |
| MEDP Medpace Holdings, Inc. compare | 0.8× |
| Diagnostics & Research industry median | 2.3× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on ICLR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement